![](https://webarchive.library.unt.edu/eot2008/20090514072024im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514072024im_/http://www.cancer.gov/images/spacer.gif)
| A drug that is being studied for its ability to enhance the effectiveness of fluorouracil and prevent gastrointestinal side effects caused by fluorouracil. It belongs to the family of drugs called antimetabolites. |
Previous Definitions: | RSV, RTA 744, RU 486, Rubex, rV-TRICOM | Next Definitions: | S-phase fraction, S100 calcium binding protein A8, S100 calcium binding protein A9, sacrum, safingol |
|
![](https://webarchive.library.unt.edu/eot2008/20090514072024im_/http://www.cancer.gov/images/spacer.gif) |